UNICHEMLAB530.00

Unichem Laboratories Limited

· Pharma & Health
₹ CrorePeersGUFICBIORPGLIFEGUJTHEMSMSPHARMAORCHPHARMAINDSWFTLABSOLARAFDCMcap ₹3,731 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity-2.985.619.309.30
Return on Assets-2.223.856.776.77
Return on Capital Employed-0.535.442.072.07
Return on Invested Capital-0.534.471.763.16
Margins
EBITDA Margin5.8812.558.369.90
Operating Margin-0.766.652.682.68
Incremental Operating Margin37.75-89.40
Pretax Margin-3.627.3213.2815.18
Net Income Margin-4.136.5111.4813.21
FCF Margin-0.34-6.84-5.42-5.42
Additional
Effective Tax Rate-14.2811.0413.5213.02
Dvd Payout Ratio-0.300.250.00
Sustainable Growth Rate-2.995.609.309.30
Incremental Operating Margin %37.75-89.4043.63
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.